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Abstract
Objective: The aim of this study was to compare preemptive analgesia of oral ketorolac plus submucous local 
placebo with oral ketorolac plus submucous local tramadol after impacted mandibular third molar surgery. 
Study design: A double-blind, randomized, placebo-controlled clinical trial was conducted. Patients were rand-
omized into two treatment groups (n = 15 per group):  group A, oral ketorolac 10 mg, 30 minutes before surgery 
plus submucous local placebo (1 mL saline solution); group B, oral ketorolac 10 mg, 30 minutes before surgery 
plus submucous local tramadol (50 mg diluted in 1 mL saline solution).  We evaluated the intensity of pain, time 
for the first analgesic rescue medication, and total analgesic consumption. 
Results: Pain intensity, number of patients requiring analgesic rescue medication, number of patients in each group 
not requiring analgesic rescue medication, and total analgesic consumption showed statistical significance. 
Conclusions: Preemptive use of oral ketorolac plus submucous local tramadol is an alternative treatment for acute 
pain after surgical removal of an impacted mandibular third molar.
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Introduction
Third molar surgery is the most common procedure 
carried out by oral and maxillofacial surgeons, and it is 
a common model for evaluating the efficacy of analge-
sics for acute dental pain relief (1). Pain associated with 
surgical removal of mandibular third molars ranges 
between moderate and severe during the first 24 hours 
(h) after surgery, with pain peaking between 6 and 8 h 
when a conventional local anesthetic is used (2).  It has 
been suggested that preemptive analgesia is an alterna-
tive for treating the postsurgical pain associated with 
third molar removal (3). 
Various analgesics have been used for this purpose, in-
cluding nonsteriodal anti-inflammatory drugs (NSAIDs) 
and some opioids (4,5). Ketorolac is an NSAID that has 
been shown to be effective after oral and parenteral 
administration. As with other NSAIDs, ketorolac pro-
duces its effect through the inhibition of prostaglandin 
synthesis, the fatty acid that promotes pain. Because of 
its efficacy and high potency, additional mechanisms of 
action have been proposed, including a modulator ef-
fect on opioid receptors and stimulation of nitric oxide 
release (6).
Tramadol is an opioid analgesic (OA) that is clinically 
effective in treating moderate to severe pain; it has a 
low addiction potential. It is used against multiple acute 
pain conditions, including postsurgical pain. It acts on 
opioid receptors and seems to modify the transmission 
of pain, inhibiting the reuptake of monoamines (7). 
Previously, we reported that local submucous trama-
dol administration is effective in reducing pain after 
impacted mandibular third molar removal (8), as well 
as prolonging the time of local anesthesia produced by 
articaine (9). The objective of this study was to compare 
the preemptive analgesia of oral ketorolac plus submu-
cous (s.m.) local placebo with oral ketorolac plus s.m. 
local tramadol after impacted mandibular third molar 
surgery. Our hypothesis is that oral ketorolac plus s.m. 
local tramadol administered preoperatively produces a 
superior postoperative analgesic effect compared with 
oral ketorolac plus s.m. local placebo. 
 
Materials and Methods
This study was a double-blind, randomized, placebo-
controlled clinical trial conducted in accordance with 
the Declaration of Helsinki. The Ethics Committee of 
the Faculty of Dentistry at San Luis Potosí University, 
Mexico, approved this study. All subjects were informed 
of the possible risks of oral surgery and treatments used. 
Each patient accepted and signed an informed consent 
form. 
The sample size was calculated as 15 patients in each 
group with a type I error of 0.05 and statistical power 
of 80%, using as response variable the first analgesic 
rescue medication for postoperative pain. One hundred 
and twenty minutes (min.) was considered a significant 
clinical difference, with an estimated mean SD of 113 
min. obtained in a previous study that evaluated the 
efficacy of tramadol administered in a combination of 
routes for reducing pain after removal of an impacted 
mandibular third molar (7). Accordingly, we obtained 
a total of 13 patients but, allowing for a possible loss 
of 10% in each group, 15 patients were included. Our 
reasoning was that this number of patients was consi-
dered acceptable to demonstrate significant differences 
attributable to the experimental therapy used.
Inclusion criteria were as follows: age 18 to 25 years, 
either gender, free of systemic disease, clinical and ra-
diographic diagnosis of an impacted mandibular third 
molar, no pain associated with the subject third molar 
up to the day of the surgery, and grade II or III difficulty 
of extraction. Exclusion criteria included the use of a-
nalgesics 24 h before the procedure, history of seizure 
disorder, pregnancy or lactation, oral contraceptive use, 
known hypersensitivity to the study medications. 
Patients were randomized into two treatment groups, 
each with 15 patients, using a series of random num-
bers:  Group A, oral ketorolac 10 mg, 30 min. before 
surgery plus s.m. local placebo (1 millilitre (ml) saline 
solution); Group B, oral ketorolac 10 mg plus s.m. local 
tramadol 50 mg diluted in 1 ml saline solution. 
All surgical procedures were carried out in the Depart-
ment of Oral and Maxillofacial Surgery by the same sur-
geon, and evaluations were carried out by an indepen-
dent investigator. Anesthesia was by nerve block of the 
lingual, buccal, and inferior alveolar nerves using two 
1.8-mL capsules of 4% articaine containing 1:100,000 
epinephrine (Medicaine, Septodont, France), after tra-
madol or a placebo were administered in the same area 
using an insulin syringe. Once anesthesia was obtained, 
surgery was started. A mucoperiosteal flap was pre-
pared by making an incision distal to the lower second 
molar along the anterior edge of the ascending ramus of 
the mandible. This flap was used to close the surgical 
wound. Suturing was done with 4-0 silk. Difficulty of 
extraction was based on a modified scale of Parant, as 
follows: Grade I, extraction with forceps and elevators; 
Grade II, extraction by osteotomy; Grade III, extraction 
by osteotomy and coronal section; Grade IV, extrac-
tion by osteotomy, root and coronal section; Grade V, 
complex extraction; Grade Vl, extraction with special 
techniques. In all cases, duration of the operation (from 
incision to final suture) was recorded. In each patient, a 
partial bony impacted mandibular third molar was ex-
tracted.
A 100-mm visual analog scale (VAS) was used to as-
sess pain. The VAS consisted of an interval scale ran-
ging from 0, representing no pain or discomfort, to 100, 
representing maximum pain or discomfort. The VAS 
report was recorded each hour for 12 h after comple-
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tion of surgery, and a last evaluation was done at 24 h 
postsurgery. Patients were given four oral ketorolac 10 
mg pills and were instructed to take one pill for rescue 
analgesic medication at least 6 hours apart, according 
to their requirements.  An evaluation format was given 
to each patient to document the time of taking the first 
ketorolac after the surgery. At the end of the evaluation 
period (24 h), the patients returned the unused ketoro-
lac. The pills were counted (also those patients in each 
group not needing any pills) to determine the number of 
consumed pills. 
Those patients having no pain relief 30 min. after taking 
oral ketorolac 10 mg were given Ketorolac 30 mg sub-
lingual as a rescue analgesic. Patients were contacted 
by telephone the evening of the surgery to assess the 
incidence of adverse events or symptoms, either from 
medications or surgical complications; they returned to 
the clinic after 1 week for suture removal. Both patients 
and the independent evaluator were blinded regarding 
the administered treatment.
Qualitative variable data are expressed as percentages 
or proportions. The Fisher exact test was used for sta-
tistical analysis of nominal variables, and the Mann-
Whitney U test was employed for ordinal variables. For 
quantitative variables, the data are shown as means and 
standard deviations. If the variable presented a normal 
distribution, the Student t test was utilized; when this 
requirement was not met, the Mann-Whitney U test 
was used. We carried out time-event curves to indicate 
the percentage of patients in each group not taking an-
algesics. These percentages were compared using the 
Log-Rank test. For all tests, a difference was considered 
significant if the probability that it occurred by chance 
alone was less than 5% (P < 0.05). 
Results
Demographic characteristics and variables describing 
the difficulty of surgery were similar among the groups 
(Table 1). 
(Fig. 1) shows the pain intensity evaluated with the VAS. 
The time for the first rescue analgesic medication post-
surgery was not significantly statistically different (P > 
.05), but the number of patients who took ketorolac 10 
mg orally as the first rescue analgesic was significantly 
less in group B (P < .05). The number in each group 
not requiring any rescue analgesic medication during 
the period of evaluation (24 h) showed a statistically sig-
nificant difference (P < 0.05) (Table 2).
Patients taking rescue analgesic medication throughout 
the 12 h are shown on the time-event curve in (Fig. 2). 
The curves show the time at which each patient con-
sumed the first rescue analgesic medication and the per-
centage of patients in each group who had not received 
any rescue analgesic (P < 0.05). The end of each curve 
indicates the proportion of patients in each group who 
did not take the first rescue analgesic medication during 
the first 12 h after surgery (P < 0.05). 
Total analgesic consumption for group A was signifi-
cantly great than that of group B (P < 0.05). During the 
evaluation period, two group A patients required rescue 
Variable
Group A 
(n = 15) 
Group B 
(n = 15) 
P
Value
Gender (male / female) 11 / 4 9 / 6 .69 
Age (mean ± SD) 20 ± 1 20. 33 ± 1 .54 
Weight (mean ± SD) 60.86 ± 9 57 ± 9 .28 
Duration of operation* (mean ± SD) 5 ± 1 6 ± 1 .12 
Surgical difficulty† (Grade II / Grade III) 10 / 5 13 / 2 .20 
Table 1. Demographic and surgical variables.
Group A = Oral ketorolac plus s.m. local placebo; Group B = Oral 
ketorolac plus s.m. local tramadol; SD =  Standard deviation.
* Duration of operation is expressed in minutes.
† Surgical difficulty: Grade II = Extraction by osteotomy; Grade 
III = Extraction by osteotomy and coronal section.
Fig. 1. Pain intensity means during first 12 hours postsurgery 
(*P < 0.05). 
Fig. 2. Time-event curves of the first 12 h postsurgery.
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medication with sublingual ketorolac 30 mg compared 
with one group B patient (Table 2). There were no com-
plications associated with the surgical procedure itself, 
and no patients reported adverse events associated with 
the medications.
Discussion
This study demonstrated that oral administration of 10 
mg ketorolac plus 50 mg of tramadol administered s.m. 
showed clear differences in the need for postoperative 
analgesic consumption compared with the group receiv-
ing 10 mg oral ketorolac plus a local placebo s.m. We 
found that only 1 patient in group A needed no pain 
medication within 12 h after surgery compared with 10 
patients from group B. We found statistically significant 
differences between groups in pain intensity measured 
by VAS at 6 h postsurgery. However, it seems that this 
difference evaluated by itself does not have clinical 
significance for pain relief because of its subjective as-
sessment; however, we consider the clear difference in 
analgesic consumption after treatment to be clinically 
relevant.
The topic of preemptive analgesia is controversial; there 
have been reports in favor as well those against. For this 
reason, some guidelines have been developed to assess 
the quality of reports of randomized clinical trials in 
pain research. It has been reported that blind assess-
ments produce significantly lower and more consistent 
scores than do open assessments (10). Furthermore, a 
meta-analysis by Ong et al. (11) assessing the ability of 
preemptive analgesic interventions to attenuate postop-
erative pain scores, decrease postoperative analgesic re-
quirements, and prolong the time to first rescue analge-
sia demonstrated an overall beneficial effect in selected 
analgesic regimens that was most pronounced after epi-
dural analgesia, local wound infiltrations, and systemic 
NSAID administration. This meta-analysis also showed 
many deficiencies in the design of randomized clinical 
trials in the field of oral surgery.
Pre- or postoperative administration of 550 mg naprox-
en or 1,000 mg diflunisal orally produces good pain 
relief after surgical removal of impacted third molars. 
However, no significant differences were found in either 
study about pain relief between the pre- and postopera-
tive approaches (12,13). A study using preemptive analge-
sia showed that tramadol 50 mg intravenous (i.v.) is more 
effective than oral tramadol 50 mg in relieving pain after 
third molar surgery (14). Another study demonstrated 
that ketorolac 30 mg i.v. produces better preventive a-
nalgesic efficacy than tramadol 50 mg i.v. when admi-
nistered preoperatively in third molar surgery (15).
One approach to overcoming these therapeutic limita-
tions is to maximize drug levels at the site of action and 
minimize systemic exposure by administering the drug 
directly to the site of tissue injury. Local application of 
aspirin and acetaminophen at subtherapeutic doses (50 
mg) has been shown to produce analgesia superior to 
Variable
Group A 
(n = 15) 
Group B 
(n = 15) 
    
P Value
Time of first rescue analgesic 
medication, minutes (Mean ± SD) 307.9 ± 
119
308 ± 134 .93 
Number (%) of patients who 
consumed the first rescue analgesic 
medication during the period of 
evaluation (12 h) 
14
(93.33) 5 (33.33) .001 
Number (%) of patients requiring no 
rescue analgesic medication during 
the period of evaluation (24 h) 
1 (6.67) 7 (46.66) .03 
Total analgesic consumption during 
24 hours (Mean ± SD) 3 ± 1 1.8 ± 2 .04 
Number (%) of patients requiring 
rescue analgesic medication (12 h) 2 (13.33) 1 (6.67) .88 
Table 2. Variables evaluated as indicators of analgesic efficacy.
Group A = Oral ketorolac plus s.m. local placebo; Group B = Oral ketorolac plus s.m. 
local tramadol; SD = Standard deviation.
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the placebo (16). An aspirin solution applied topically in 
the oral cavity has an analgesic effect on experimental 
and clinical pain, which appears to be mediated locally 
and not by systemic absorption (17). Ketoprofen 10 mg 
administered into the two mandibular extraction sites 
showed better analgesic efficacy than a 25-mg ketopro-
fen oral capsule. In addition, plasma concentrations of 
10-mg ketoprofen were lower than the 25-mg oral cap-
sule of ketoprofen (18).
We believe that the local administration of analgesics 
may also be an acceptable alternative to the use of 
NSAIDs in the oral cavity, particularly in patients with 
increased risk of gastrointestinal bleeding after enteral 
administration (19,20). On the other hand, reduction in 
plasma concentration of any NSAID is desirable owing 
to alterations in renal function associated with the in-
gestion of these drugs, which are estimated to occur in 
approximately 1% of exposed patients (21).
The main finding of this study is that, in patients under-
going removal of an impacted mandibular third molar, 
treatment with preemptive ketorolac plus s.m. local tra-
madol resulted in an important reduction in consump-
tion of postoperative analgesics. This study suggests 
that the use of ketorolac, along with s.m. local tramadol 
in a regimen of preemptive analgesia, represents an al-
ternative for the treatment of acute pain after removal of 
an impacted mandibular third molar.
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